Komori
Tohoku Chemical (7446) · InitiativeAcquisition of 31 odd-lot shares

Acquisition of 10,000 treasury shares

First written in FY2016-Q3. 6 of 18 entries say "Restated". Latest entry: FY2025.

18entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2016-Q3 – FY2016OtherFY2023 – FY20252016: 220162017: 120172018: 220182019: 120192020: 220202021: 420212022: 320222023: 120232024: 120242025: 12025
Same theme, other companies
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 1292 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025Acquisition of 31 odd-lot sharesAnnual report

    「Treasury shares acquired during the fiscal year 31 125,550」

    In FY2025, 31 treasury shares were acquired through the purchase of odd-lot shares for ¥125,550, bringing treasury shares held at period-end to 59,042.
  2. FY2024Acquisition of 34 odd-lot sharesAnnual report

    「Treasury shares acquired during the fiscal year 34 132,940 The main component of the increase was purchases made in response to requests for the purchase of odd-lot shares.」

    Following no treasury share acquisitions in FY2023, 34 treasury shares were acquired during the fiscal year through requests for the purchase of odd-lot shares, for ¥132,940.
  3. FY2023No treasury shares acquired during the fiscal yearAnnual report

    「Not applicable.」

    There were no applicable matters concerning treasury share acquisitions based on a resolution of the general meeting of shareholders, a resolution of the Board of Directors or acquisitions not based on a resolution, and treasury shares held at period-end totaled 58,977.
  4. FY2022AdvancedAnnual report

    「Resolution by the Board of Directors (12 November 2021) (acquisition period: 15 November 2021) 12,000 38,400,000」

    Against the resolution to acquire 12,000 shares for ¥38,400,000, 11,000 shares were acquired during the fiscal year for ¥35,200,000, and the remaining 1,000 shares and ¥3,200,000 were disclosed as unexercised.
  5. FY2022-Q2RestatedAnnual report

    「Payments for the acquisition of treasury shares △ 35,340」

    Payments of ¥35.34 million for the acquisition of treasury shares were recorded for the cumulative second quarter of the fiscal year on a consolidated basis. The impact of acquisitions carried out by the previous quarter continues to be reflected in financing activities.
  6. FY2022-Q1RestatedAnnual report

    「The main factor behind the increase in net assets was a ¥90 million increase in retained earnings, despite a ¥35 million decrease resulting from the acquisition of treasury shares.」

    The ¥35 million reduction in net assets resulting from the acquisition of treasury shares is reflected in the financial position for the first quarter of the current fiscal year.
  7. FY2021AdvancedAnnual report

    「Resolution by the Board of Directors (13 November 2020) (acquisition period: 16 November 2020) 21,300 67,840,500」

    Pursuant to a resolution of the Board of Directors, 21,300 treasury shares were acquired during the fiscal year for ¥67.8405 million, bringing treasury shares held at period-end to 47,977.
  8. FY2021-Q3RestatedAnnual report

    「The main factors behind the increase in net assets were an increase of ¥343 million in retained earnings and an increase of ¥138 million in valuation difference on available-for-sale securities, despite a ¥68 million decrease resulting from the acquisition of treasury shares.」

    The ¥68 million reduction in net assets resulting from the acquisition of treasury shares continues to be reflected in the financial position. No new acquisition resolution or number of shares acquired is stated in the quarterly report for the current period.
  9. FY2021-Q2RestatedAnnual report

    「Payments for the acquisition of treasury shares △ 68,040」

    Payments of ¥68.04 million for the acquisition of treasury shares continue to be recorded under financing activities.
  10. FY2021-Q1AdvancedAnnual report

    「The main factors behind the increase in net assets were an increase of ¥70 million in valuation difference on available-for-sale securities and an increase of ¥13 million in retained earnings, despite a ¥68 million decrease resulting from the acquisition of treasury shares.」

    It is stated that the acquisition of treasury shares reduced net assets by ¥68 million, and the continued acquisition of treasury shares from the previous fiscal year is reflected in the financial position for the first quarter of the current fiscal year.
  11. FY2020AdvancedAnnual report

    「Resolution by the Board of Directors (3 February 2020) (acquisition period: 4 February 2020) 4,000 12,840,000」

    Pursuant to a resolution of the Board of Directors, 4,000 treasury shares were acquired during the fiscal year for ¥12.84 million, bringing treasury shares held at period-end to 26,677.
  12. FY2020-Q2ReframedAnnual report

    「Payments for the acquisition of treasury shares — △12,891」

    Payments of ¥12.891 million for the acquisition of treasury shares were incurred during the cumulative second quarter of the fiscal year on a consolidated basis. The status changed from no treasury share acquisitions previously to an acquisition during the fiscal year.
  13. FY2019No treasury shares acquired during the fiscal yearAnnual report

    「Current fiscal year」

    There were no treasury share acquisitions during the fiscal year, and treasury shares held at period-end totaled 22,677.
  14. FY2018ReframedAnnual report

    「Resolution by the Board of Directors (23 April 2018) (acquisition period: 23 April 2018) 14 shares ¥48,960」

    The report states that 14 shares were acquired in connection with the treatment of fractional shares following a share consolidation, in addition to 260 shares acquired through the purchase of odd-lot shares. Treasury share acquisitions have shifted from large-scale purchases to purchases mainly involving fractional and odd-lot shares.
  15. FY2018-Q2RestatedAnnual report

    「Payments for the acquisition of treasury shares △¥128 thousand」

    Payments of ¥128 thousand for the acquisition of treasury shares are reported for the cumulative second quarter of the fiscal year on a consolidated basis.
  16. FY2017ReframedAnnual report

    「Treasury shares acquired during the fiscal year 786 shares ¥477,028」

    Unlike the acquisition of 10,000 shares pursuant to the previous Board of Directors resolution, 786 shares were acquired during the fiscal year through the purchase of odd-lot shares. Treasury shares held at period-end totaled 112,813.
  17. FY2016RestatedAnnual report

    「Resolution by the Board of Directors (15 June 2016) (acquisition period: 15 June 2016 to 15 June 2016) 10,000 shares ¥4,860,000」

    The acquisition of 10,000 treasury shares and 112,027 treasury shares held at period-end are stated, confirming in the annual report the acquisition details previously reported in the quarterly report.
  18. FY2016-Q3First statedAnnual report

    「Following the acquisition of 10,000 treasury shares pursuant to a resolution of the Board of Directors held on 15 June 2016, the number of treasury shares held at the end of the third quarter accounting period was 112,027.」

    It is stated that treasury shares were acquired pursuant to a resolution of the Board of Directors. The number of shares acquired, the resolution date and the number of treasury shares held at period-end are provided.
Moved together

"Improving Performance Through Revenue and Profit Growth" moved the same way as this thread, in the same document, in 5 of its 18 moves.

555332★123456
  1. ★This thread
  2. 1Improving Performance Through Revenue and Profit Growth5×
  3. 2Recovery in demand related to electronic components and generic pharmaceuticals5×
  4. 3Expanding demand, new adoption and margin improvement for clinical laboratory reagents5×
  5. 4Decline in cash and cash equivalents and cash outflows from operating activities3×
  6. 5Increase in Total Assets, Liabilities and Net Assets3×
  7. 6Stagnant capital investment and an uncertain outlook due to yen appreciation, falling share prices and slowing overseas economies2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Tohoku Chemical's next results are scheduled for 2026-11-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.